Skip to content
Subscribe
Newsletter
Advertise
MDA.org
Donate
Subscribe
Donate
Menu
Magazine
Current Issue
Past Issues
Featured Content
Topics
Advocacy
Finding a Diagnosis
Get Involved
Health
Inclusion
Independence
Lifestyle
News
Personal Stories
Science + Research
Diseases A-Z
Quest Blog
Podcast
Product Guide
News
Read the latest news about issues affecting the neuromuscular disease community.
Blog Post
Newborn Screening for DMD and BMD: MDA Needs Your Help
By
MDA Staff
|
January 15, 2019
Blog Post
Clinical Trial Alert: Orphazyme Seeks Participants for a Phase 3 ALS Study
By
MDA Staff
|
January 11, 2019
Blog Post
Clinical Trial Alert: Catabasis Seeks Participants for a Phase 3 DMD Study
By
MDA Staff
|
January 10, 2019
Blog Post
Wave Life Sciences Announces Phase 2/3 Duchenne Muscular Dystrophy Clinical Trial of Suvodirsen (WVE-210201) Selected for FDA Complex Innovative Trial Designs Pilot Program
By
Jeanene Swanson
|
January 8, 2019
Blog Post
FDA Grants Orphan Drug Designation to Myonexus Therapeutics’ MYO-102 Gene Therapy Drug for Limb-Girdle Muscular Dystrophy Type 2D
By
Jeanene Swanson
|
January 4, 2019
Blog Post
FDA Announces the Approval of TIGLUTIK, an Oral Suspension Form of riluzole, for the Treatment of ALS
By
MDA Staff
|
September 10, 2018
Blog Post
FDA Approves Radicava to Treat ALS
By
Amy Madsen
|
May 6, 2017
Blog Post
National ALS Registry Now Open
By
Miriam Davidson
|
October 19, 2010
« Previous
1
…
19
20
21
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset